Citigroup’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-85,757
| Closed | -$9.2M | – | 5034 |
|
|
2023
Q1 | $9.2M | Buy |
85,757
+52,077
| +155% | +$5.59M | 0.01% | 878 |
|
|
2022
Q4 | $3.7M | Sell |
33,680
-53,685
| -61% | -$5.91M | ﹤0.01% | 1197 |
|
|
2022
Q3 | $5.16M | Buy |
87,365
+84,584
| +3,041% | +$4.99M | ﹤0.01% | 1120 |
|
|
2022
Q2 | $78K | Sell |
2,781
-6,501
| -70% | -$182K | ﹤0.01% | 3671 |
|
|
2022
Q1 | $350K | Buy |
9,282
+285
| +3% | +$10.7K | ﹤0.01% | 3077 |
|
|
2021
Q4 | $356K | Buy |
8,997
+7,707
| +597% | +$305K | ﹤0.01% | 3275 |
|
|
2021
Q3 | $31K | Buy |
1,290
+753
| +140% | +$18.1K | ﹤0.01% | 4267 |
|
|
2021
Q2 | $13K | Buy |
+537
| New | +$13K | ﹤0.01% | 4874 |
|